Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells

Journal of Endocrinology

Volumn 209, Issue 1, 2011, Pages 33-43

  Sakurai, Toshihiro ^a   Suzuki, Kenta ^a   Yoshie, Mikihiro ^a   Hashimoto, Keisuke ^a   Tachikawa, Eiichi ^a   Tamura, Kazuhiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; CD31 ANTIGEN; CYCLOOXYGENASE 2; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; LUTEAL CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD31; BLOTTING, WESTERN; CELLS, CULTURED; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENDOTHELIAL CELLS; FEMALE; ISOQUINOLINES; LUTEAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASE INHIBITORS; RATS; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953716806     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0357     Document Type: Article

References (52)

1. Amano H, Ito Y, Suzuki T, Kato S, Matsui Y, Ogawa F, Murata T, Sugimoto Y, Senior R, Kitasato H et al. 2009 Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis. Cancer Science 100 2318-2324. (doi:10.1111/j.1349-7006.2009.01322.x)
2. Antczak M & Van Blerkom J 2000 The vascular character of ovarian follicular granulosa cells: phenotypic and functional evidence for an endothelial-like cell population. Human Reproduction 15 2306-2318. (doi:10.1093/humrep/15.11.2306)
3. Arosh JA, Banu SK, Chapdelaine P, Madore E, Sirois J & Fortier MA 2004 Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function. Endocrinology 145 2551-2560. (doi:10.1210/en.2003-1607)
4. 2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells suppression of ERK1/2, AKT, NFκB, and β-catenin pathways and activation of intrinsic apoptotic mechanisms. Molecular Endocrinology 23 1291-1305. (doi:10.1210/me.2009-0017)
5. 2 promote endothelial barrier enhancement via PKA- and Epac1/Rap1- dependent Rac activation. Experimental Cell Research 313 2504-2520. (doi:10.1016/j.yexcr.2007.03.036)
6. Bogan RL, Murphy MJ, Stouffer RL & Hennebold JD 2008 Prostaglandin synthesis, metabolism, and signaling potential in the rhesus macaque corpus luteum throughout the luteal phase of the menstrual cycle. Endocrinology 149 5861-5871. (doi:10.1210/en.2008-0500)
7. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP & Versteeg HH 2004 Prostanoids and prostanoid receptors in signal transduction. International Journal of Biochemistry and Cell Biology 36 1187-1205. (doi:10.1016/j.biocel.2003.08.006)
8. 2α in bovine luteal steroidogenic cells. Biology of Reproduction 79 310-317. (doi:10.1095/biolreprod.107.066084)
9. Brown CG & Poyser NL 1984 Studies on ovarian prostaglandin production in relation to ovulation in the rat. Journal of Reproduction and Fertility 72 407-414. (doi:10.1530/jrf.0.0720407)
10. Bryant CE, Appleton I & Mitchell JA 1998 Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells. Life Sciences 62 2195-2201. (doi:10.1016/S0024-3205(98)00197-0)
11. Cha ST, Talavera D, Demir E, Nath AK & Sierra-Honigmann MR 2005 A method of isolation and culture of microvascular endothelial cells from mouse skin. Microvascular Research 70 198-204. (doi:10.1016/j.mvr.2005.08.002)
12. 2 in human granulosa-lutein cells. Journal of Endocrinology 194 595-602. (doi:10.1677/JOE-07-0128)
13. 2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. PNAS 101 7220-7225.
14. 2 receptor. Prostaglandins and Other Lipid Mediators 76 48-58. (doi:10.1016/j.prostaglandins.2004.12.001)
15. Christenson LK & Stouffer RL 1996 Isolation and culture of microvascular endothelial cells from the primate corpus luteum. Biology of Reproduction 55 1397-1404. (doi:10.1095/biolreprod55.6.1397)
16. Davis JS, Rueda BR & Spanel-Borowski K 2003 Microvascular endothelial cells of the corpus luteum. Reproductive Biology and Endocrinology 1 89. (doi:10.1186/1477-7827-1-89)
17. Ferrara N & Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocrine Reviews 18 4-25. (doi:10.1210/er.18.1.4)
18. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ & Schwall RH 1998 Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Medicine 4 336-340. (doi:10.1038/nm0398-336)
19. Findlay JK 1986 Angiogenesis in reproductive tissues. Journal of Endocrinology 11 357-366. (doi:10.1677/joe.0.1110357)
20. 2 primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circulation Research 105 657-666. (doi:10.1161/CIRCRESAHA.109.203760)
21. 1 in osteoblasts. Journal of Clinical Investigation 93 2490-2496. (doi:10.1172/JCI117258)
22. Kaczmarek MM, Schams D & Ziecik AJ 2005 Role of vascular endothelial growth factor in ovarian physiology - an overview. Reproductive Biology 5 111-136.
23. 2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 25 7019-7028. (doi:10.1038/sj.onc.1209694)
24. Kashida S, Sugino N, Takiguchi S, Karube A, Takayama H, Yamagata Y, Nakamura Y & Kato H 2001 Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats. Biology of Reproduction 64 317-323. (doi:10.1095/biolreprod64.1.317)
25. Kossowska-Tomaszczuk K, De Geyter C, De Geyter M, Martin I, Holzgreve W, Scherberich A & Zhang H 2009 The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells 27 210-219. (doi:10.1634/stemcells.2008-0233)
26. 2 and tumor necrosis factor alpha on the VEGF-receptor system expression in cultured porcine luteal cells. Molecular Reproduction and Development 75 1558-1566. (doi:10.1002/mrd.20897)
27. Lopes FL, Desmarais J, Ledoux S, Gévry NY, Lefevre P & Murphy BD 2006 Transcriptional regulation of uterine vascular endothelial growth factor during early gestation in a carnivore model, Mustela vison. Journal of Biological Chemistry 281 24602-24611. (doi:10.1074/jbc.M602146200)
28. Mukherjee R, Edwards J, Underwood MA & Bartlett JM 2005 The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer. BJU International 96 62-66. (doi:10.1111/j.1464-410X.2005.05568.x)
29. Myers M, van den Driesche S, McNeilly AS & Duncan WC 2008 Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro. Journal of Endocrinology 199 201-212. (doi:10.1677/JOE-08-0302)
30. 2 receptors EP2 and EP4 in human ovarian granulosa-luteal cells. Journal of Clinical Endocrinology and Metabolism 86 1765-1768. (doi:10.1210/jc.86.4.1765)
31. Nie D & Honn KV 2004 Eicosanoid regulation of angiogenesis in tumors. Seminars in Thrombosis and Hemostasis 30 119-125. (doi:10.1055/s-2004-822976)
32. Okuda K, Sakamoto R, Uenoyama Y, Berisha B, Miyamoto A & Schams D 1999 Tumor necrosis factor alpha receptors in microvascular endothelial cells from bovine corpus luteum. Biology of Reproduction 61 1017-1022. (doi:10.1095/biolreprod61.4.1017)
33. Olofsson JI & Leung PC 1996 Prostaglandins and their receptors: implications for ovarian physiology. Biological Signals 5 90-100. (doi:10.1159/000109178)
34. Pauli SA, Tang H, Wang J, Bohlen P, Posser R, Hartman T, Sauer MV, Kitajewski J & Zimmermann RC 2005 The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critiacal for blood vessel survival in corpora lutea of pregnancy in the rodent. Endocrinology 146 1301-1311. (doi:10.1210/en.2004-0765)
35. Ratcliffe KE, Anthony FW, Richardson MC & Stones RW 1999 Morphology and functional characteristics of human ovarian microvascular endothelium. Human Reproduction 14 1549-1554. (doi:10.1093/humrep/14.6.1549)
36. Regan JW 2003 EP2 and EP4 prostanoid receptor signaling. Life Sciences 74 143-153. (doi:10.1016/j.lfs.2003.09.031)
37. Reynolds LP & Redmer DA 1998 Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor in the ovary. Journal of Animal Science 76 1671-1681.
38. Reynolds LP, Grazul-Bilska AT & Redmer DA 2002 Angiogenesis in female reproductive organs: pathological implication. International Journal of Experimental Pathology 83 151-163. (doi:10.1046/j.1365-2613.2002.00277.x)
39. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM et al. 2010 Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468 824-828. (doi:10.1038/nature09557)
40. Sakurai T, Tamura K, Okamoto S, Hara T & Kogo H 2003 Possible role of cyclooxygenase II in the acquisition of ovarian luteal function in rodents. Biology of Reproduction 69 835-842. (doi:10.1095/biolreprod.102.010710)
41. Sakurai T, Tamura K & Kogo H 2004 Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membraneassociated prostaglandin E synthase in rat luteal cells. Journal of Endocrinology 183 527-533. (doi:10.1677/joe.1.05629)
42. Sakurai T, Tamura K & Kogo H 2005 Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitortreated rats. European Journal of Pharmacology 16 158-164. (doi:10.1016/j.ejphar.2005.03.003)
43. Shweiki D, Itin A, Neufeld G, Gitay-Goren H & Keshet E 1993 Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Journal of Clinical Investigation 91 2235-2243. (doi:10.1172/JCI116450)
44. 2 results in suppression of skin tumor development. Cancer Research 65 9304-9311. (doi:10.1158/0008-5472.CAN-05-1015)
45. 2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascular Pharmacology 44 411-416. (doi:10.1016/j.vph.2006.02.009)
46. Taniguchi T, Fujino H, Israel DD, Regan JW & Murayama T 2008 Human EP3(I) prostanoid receptor induces VEGF and VEGF receptor-1 mRNA expression. Biochemical and Biophysical Research Communications 377 1173-1178. (doi:10.1016/j.bbrc.2008.10.140)
47. Thurton LM, Chin E, Jonas KC, Bujalska IJ, Stewart PM, Abayasekara DR & Michael AE 2003 Expression of 11β-hydroxysteroid dehydrogenase (11(HSD) proteins in luteinizing human granulosa-lutein cells. Journal of Endocrinology 178 127-135. (doi:10.1677/joe.0.1780127)
48. 2 signals monocyte/macrophage survival to peroxynitrite via protein kinase A converging in bad phosphorylation with the protein kinase C alphadependent pathway driven by 5-hydroxyeicosatetraenoic acid. Journal of Immunology 181 5637-5645.
49. Tuckey RC 2005 Progesterone synthesis by the human placenta. Placenta 26 273-281. (doi:10.1016/j.placenta.2004.06.012)
50. 2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptormediated cAMP pathway. Molecular Endocrinology 23 1291-1305. (doi:10.1210/me.2009-0017)
51. Wilson RJ & Giles H 2005 Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP, and IP receptor subtypes. British Journal of Pharmacology 144 405-415. (doi:10.1038/sj.bjp.0706088)
52. 2 in esophageal squamous-cell carcinoma. Journal of Pharmacology and Experimental Therapeutics 327 258-267. (doi:10.1124/jpet.108.141275)